The nation of Zimbabwe has rejected a major US health deal valued at $367m (£272m) over five years due to the United States' insistence on confidential biological samples.
This rejection was revealed after a official document dated December was disclosed, which showed President Emmerson Mnangagwa believed the deal was "lopsided".
An official spokesman has since clarified that the US was demanding access to genetic material for scientific study and profit but refused to guarantee the resulting advantages from future vaccines.
"We are forced to start the difficult and regrettable process of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has appealed for continued dialogue to reach a deal suitable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Implications
This rejection follows a similar case in Kenya, where a court halted a similar health funding agreement following legal challenges were raised about the security of citizens' medical information.
After returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had administered aid for the American government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral deals to enhance openness and responsibility.
Based on reports, 16 nations in Africa have so far signed similar agreements, representing over $18.3bn in new funding.
Details of the Rejected Agreement
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Effectively, our country would supply the basic resources for scientific discovery without any certainty that the final treatments would be available to our people if a future pandemic emerge."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one deals were undermining frameworks already set up via the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential pandemics.
"This system is designed to guarantee that when a nation provides its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," he added.
"We are open to continued dialogue with our American counterparts on how subsequent co-operation could be designed in a manner that respects the sovereignty and dignity of each country."
Medical Community Reaction
A leading public health body stated it recognised the official position, but recommended that talks must proceed since a large portion of the country's HIV programmes relied on foreign aid.
"In cases where technical issues arise, including those involving information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group commented.
The situation underscores the ongoing debate between receiving vital foreign assistance and protecting local interests in an ever more interconnected world.